Ocean Biomedical, Inc.
OCEA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | – | $0 | $0 |
| Gross Profit | $0 | – | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | – | $0 | $34 |
| G&A Expenses | $4 | – | $0 | $28 |
| SG&A Expenses | $4 | – | $2 | $28 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $0 | -$62 |
| Operating Expenses | $4 | – | $2 | $1 |
| Operating Income | $0 | – | -$2 | -$1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | – | $2 | $0 |
| Pre-Tax Income | -$3 | – | -$1 | -$1 |
| Tax Expense | $0 | – | $0 | $0 |
| Net Income | -$3 | – | $1 | -$62 |
| % Margin | – | – | – | – |
| EPS | -0.12 | – | -0.047 | -0.043 |
| % Growth | – | – | -11.3% | – |
| EPS Diluted | -0.12 | – | -0.047 | -0.043 |
| Weighted Avg Shares Out | 28 | – | 19 | 13 |
| Weighted Avg Shares Out Dil | 28 | – | 19 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $2 | $0 |
| Interest Expense | -$2 | – | $0 | $0 |
| Depreciation & Amortization | $0 | – | $0 | $0 |
| EBITDA | $0 | – | -$1 | -$0 |
| % Margin | – | – | – | – |